Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 747.07 Delayed Data As of Jun 09 |  -3.05 / -0.41%Today’s Change | 538.01 Today|||52-Week Range 837.55 | +3.55% Year-to-Date |
Latest REGN News | Press Releases
| Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know Jun 08 / Zacks.com - Paid Partner Content | Is First Trust NASDAQ-100 Equal Weighted ETF (QQEW) a Strong ETF Right Now? Jun 01 / Zacks.com - Paid Partner Content |
| Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? Jun 07 / Zacks.com - Paid Partner Content | Kodiak (KOD) Advances With Tarcocimab Amid Stiff Competition May 30 / Zacks.com - Paid Partner Content |
| Wall Street Says These 2 Stocks May Double. Should You Buy Them? Jun 05 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 750.12 |
| Today’s open | 749.31 |
| Day’s range | 743.19 - 751.62 |
| Volume | 16,596 |
| Average volume (3 months) | 588,344 |
| Market cap | $81.2B |
Data as of 4:00pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -46.98% |
| Earnings growth (this year) | -6.64% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -24.26% |
| P/E ratio | 20.3 |
| Price/Sales | 6.73 |
| Price/Book | 3.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRTXVertex Pharmaceutica... | +1.53 | +0.46% |
| ---- | ||
| ZTSZoetis Inc | -1.21 | -0.74% |
| GSKGlaxoSmithKline | +0.04 | +0.12% |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 3, 2023 |
| EPS forecast (this quarter) | $10.29 |
| Annual revenue (last year) | $12.2B |
| Annual profit (last year) | $4.3B |
| Net profit margin | 35.64% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
